A Comprehensive Investigation of the Potential Role of Lipoproteins and Metabolite Profile as Biomarkers of Alzheimer's Disease Compared to the Known CSF Biomarkers.
Azam Sajjadi NasabFatemeh NooraniZahra PaeiziLeila KhaniSaba BanaeiMohammad SadeghiMelika ShafeghatMahan ShafieMahsa MayeliThe Alzheimer's Disease Neuroimaging Initiative AdniPublished in: International journal of Alzheimer's disease (2023)
gene status in the pathophysiology of AD development. However, further research is warranted to explore the exact association of lipoproteins and other metabolites with AD core biomarkers and pathology.